SolventumSOLV -2.13%30 Buyback Yield % is 0.50 as of Jul. 07, 2026, which is 15% below its 10-year median of 0.59. GuruFocus rates SOLV with a GF Score™ of 30/100. The stock has 8 warning signs investors should review. Among 347 Medical Devices & Instruments companies, Solventum ranks better than 73.78% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Solventum's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOLV vs COO, ALGN, BAX: Buyback Yield % Comparison
For the Medical Instruments & Supplies subindustry, Solventum's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solventum Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Solventum's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Solventum's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solventum (SOLV) has a Buyback Yield % of 0.50 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Solventum and its competitors. This is 15% below median its historical median of 0.59. Over the past decade, Solventum's Buyback Yield % has ranged from 0.50 to 0.59. According to the industry distribution chart, Solventum ranks #91 out of 347 companies in the Medical Devices & Instruments industry, placing it in the top 26.2%.
Is Solventum's Buyback Yield % too high?
Solventum's current Buyback Yield % of 0.50 is 15% below median its 10-year median of 0.59. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 0.59. Based on the distribution chart, Solventum ranks #91 out of 347 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Solventum has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Solventum's Buyback Yield % compare to COO and ALGN?
According to the Medical Devices & Instruments industry distribution chart, Solventum ranks #91 out of 347 companies for Buyback Yield %. This puts Solventum in the upper half of its industry. Historically, Solventum's own Buyback Yield % has ranged from 0.50 to 0.59 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Solventum and its competitors. Solventum's current Buyback Yield % is 0.50, which is 15% below median its own 10-year median of 0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solventum stock overvalued right now?
Solventum (SOLV) has a current Buyback Yield % of 0.50. The current Buyback Yield % is 0.50, which is 15% below median its 10-year median of 0.59. Solventum's overall GF Score™ is 30/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Solventum (SOLV), the current Buyback Yield % is 0.50 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
30GF Score
Get the complete analysis for SOLV
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SOLV has been successfully added to your 
